化学
糖萼
基质金属蛋白酶
组蛋白脱乙酰基酶
细胞生物学
失血性休克
癌症研究
血管通透性
组蛋白
药理学
HDAC6型
内皮
体外
内皮干细胞
炎症
金属蛋白酶
基质(化学分析)
血管生成
止血
基质金属蛋白酶抑制剂
休克(循环)
HDAC1型
基质金属蛋白酶9
作者
Yufang Zhang,Zheng Zhang,Yunfei Chi,Huiting Yun,Quanxi Zhang,Weihua Cao,Hailiang Bai,Bin Wei,Haiyan Liu,Jiake Li,Hongjie Duan
标识
DOI:10.1097/ta.0000000000004767
摘要
BACKGROUND: Hemorrhagic shock (HS) induces severe vascular leakage, often resulting in multiple organ dysfunction, making it a critical medical challenge. The vascular endothelial glycocalyx (vEG), which covers the endothelial surface of the blood vessels, plays a critical role in maintaining the vascular barrier function. Protection of vEG offers novel therapeutic opportunities to improve clinical symptoms in patients with HS. Valproic acid (VPA) and tubastatin A (Tub A), as histone deacetylase inhibitors, have been found to have strong prosurvival effects in animal models with HS, but their impact on the shedding of vEG is still unknown during HS. The purpose of this study is to determine the comparative therapeutic effects of Tub A and VPA in protecting vEG during HS by suppressing hypoxia-inducible factor-1α (HIF-1α)/matrix metalloproteinase 9 (MMP-9) signaling. METHODS: This study constructed rat models of HS and human umbilical vein endothelial cell models of glucose-oxygen deprivation and conducted comparative studies on the protective effects and mechanisms of Tub A and VPA on vEG shedding induced by HS, thereby improving vascular leakage. RESULTS: Pulmonary-capillary permeability and the shedding of vEG were significantly increased after HS. Tub A and VPA reduced pulmonary-capillary permeability, inhibited the degradation of vEG, and downregulated the expression of HIF-1α and MMP-9 in rats with HS, and the effect of Tub A is better than VPA. Further in vitro investigations indicated that Tub A protected against endothelial glycocalyx degradation by suppressing HIF-1α-induced overexpression of MMP-9. CONCLUSION: Tub A attenuates the increased vascular permeability induced by HS by protecting vEG via inhibiting HIF-1α/MMP-9 signaling, with superior effects over VPA. These results highlight Tub A as a promising therapeutic candidate for protecting vascular integrity during HS.
科研通智能强力驱动
Strongly Powered by AbleSci AI